Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Total-Long-Term-Liabilities" stands at 26.06 Billion Japanese Yens as of 09/30/2025, the highest value since 12/31/2020.
As of the end of Chugai Pharmaceutical Co. Ltd.'s third quarter, the item "Total Long Term Liabilities" stands at 26.06 Billion JPY. This represents an increase of 4.47 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 53.99 percent compared to the value the year prior.
The 1 year change in percent is 53.99.
The 3 year change in percent is 12.19.
The 5 year change in percent is -0.3937.
The 10 year change in percent is -2.56.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Liabilities | 280,205,508,085.11 |